Curaleaf launches $4/share takeover bid for Aurora Cannabis
Curaleaf has spread positive acquisition news in the market by proposing to acquire Aurora Cannabis at $4 per share.
The current closing price of $3.94 is positioned above the reported resistance level of $3.92, indicating a breakout signal. Considering the acquisition news and the upward patterns from similar past events, a buy has been considered.
If the price reaches the resistance level of $3.92, take profits, and if it falls to the support level of $2.59, cut losses (based on the report's calculated values).
RSI(14)=79.7 (overbought), moving averages are misaligned (trend unclear), trading volume is 0.83 times the 20-day average (weak volume), and the recent 7-day volatility is +2.1% (slight increase).
The past cases recorded significant increases of +35.9%, +31.3%, and +12.2% on August 4, 2026, August 5, 2026, and August 11, 2026, respectively, demonstrating a pattern of substantial stock price rises following the announcement of acquisitions or positive news.
The actual return recorded was 10.1%, compared to the forecasted return of 3.5%, resulting in an OVERHIT designation. The decision to buy near the resistance line and the reflection of acquisition news were accurate, but the increase was significantly underestimated despite the overheated RSI and low trading volume.
In the next trading session, we will set a more conservative target price considering the RSI overbought signal and adjust the position size until trading volume recovers. Additionally, when there are positive news such as acquisition announcements, we will quickly verify whether there is a price breakout and set the stop-loss line slightly higher than before to prepare for sudden fluctuations.